Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Comparison of split-course radiation therapy and continuous radiation therapy for unresectable bronchogenic carcinoma: 5 year results

Conference · · Am. J. Roentgenol., Radium Ther. Nucl. Med., v. 126, no. 1, pp. 116- 122
OSTI ID:4022403
One hundred and eighty-eight patients with inoperable or unresectable bronchogenic carcinoma were stratified by cell type, TNM staging, and prior surgery and then randomized into two treatment groups: continuous radiation therapy and split-course radiation therapy. There was no difference in clinical or objective improvement in the two groups. Survival rates for cases of squamous cell carcinoma, small cell carcinoma, and adenocarcinoma were the same after both regimens of therapy. Split-course therapy resulted in a significantly better survival rate in cases of large cell carcinoma but the number of cases was small. We doubt that the difference is clinically significant. Objective roentgenographic response was accompanied by improved survival in squamous cell carcinoma, but not in the other three cell types. Split-course radiation therapy is superior to continuous radiation therapy because it is better tolerated by the patient and because re-examination of the patient prior to the second half of split-course therapy permits the detection of new metastatic disease that has become manifest during the rest period and spares the patient the futile second half of radiation therapy. (auth)
Research Organization:
Mayo Clinic and Mayo Foundation, Rochester, MI
NSA Number:
NSA-33-026222
OSTI ID:
4022403
Conference Information:
Journal Name: Am. J. Roentgenol., Radium Ther. Nucl. Med., v. 126, no. 1, pp. 116- 122
Country of Publication:
United States
Language:
English

Similar Records

Bronchogenic carcinoma in breast carcinoma patients
Journal Article · Mon Jan 31 23:00:00 EST 1983 · AJR, Am. J. Roentgenol.; (United States) · OSTI ID:6222802

Bronchogenic carcinoma in breast carcinoma patients
Journal Article · Mon Jan 31 23:00:00 EST 1983 · AJR, Am. J. Roentgenol.; (United States) · OSTI ID:5578550

A pilot study with ethyl bis (2,2-dimethyl-1-aziridinyl) phosphinate (AB-163) and radiation therapy
Journal Article · Thu Jul 01 00:00:00 EDT 1982 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:6724583